444 related articles for article (PubMed ID: 15784237)
1. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic adenosine and P2Y receptors.
Gonçalves J; Queiroz G
Handb Exp Pharmacol; 2008; (184):339-72. PubMed ID: 18064419
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
4. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.
Bianco F; Fumagalli M; Pravettoni E; D'Ambrosi N; Volonte C; Matteoli M; Abbracchio MP; Verderio C
Brain Res Brain Res Rev; 2005 Apr; 48(2):144-56. PubMed ID: 15850653
[TBL] [Abstract][Full Text] [Related]
6. Purines and pain mechanisms: recent developments.
Liu XJ; Salter MW
Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
[TBL] [Abstract][Full Text] [Related]
7. [Nucleotide receptors--structure and function, history and perspectives].
Barańska J
Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
[TBL] [Abstract][Full Text] [Related]
8. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
9. Overview of the P2 receptors.
Boeynaems JM; Communi D; Gonzalez NS; Robaye B
Semin Thromb Hemost; 2005 Apr; 31(2):139-49. PubMed ID: 15852217
[TBL] [Abstract][Full Text] [Related]
10. Molecular dissection of purinergic P2X receptor channels.
Stojilkovic SS; Tomic M; He ML; Yan Z; Koshimizu TA; Zemkova H
Ann N Y Acad Sci; 2005 Jun; 1048():116-30. PubMed ID: 16154926
[TBL] [Abstract][Full Text] [Related]
11. Impact of ectoenzymes on p2 and p1 receptor signaling.
Kukulski F; Lévesque SA; Sévigny J
Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
[TBL] [Abstract][Full Text] [Related]
12. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
Fischer B; Boyer JL; Hoyle CH; Ziganshin AU; Brizzolara AL; Knight GE; Zimmet J; Burnstock G; Harden TK; Jacobson KA
J Med Chem; 1993 Nov; 36(24):3937-46. PubMed ID: 8254622
[TBL] [Abstract][Full Text] [Related]
13. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
Köles L; Furst S; Illes P
Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
[TBL] [Abstract][Full Text] [Related]
15. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
[TBL] [Abstract][Full Text] [Related]
16. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Franke H; Illes P
Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
[TBL] [Abstract][Full Text] [Related]
17. P2Y receptors: biological advances and therapeutic opportunities.
Shaver SR
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):665-70. PubMed ID: 12825461
[TBL] [Abstract][Full Text] [Related]
18. ATP stimulates peripheral axons in human, rat and mouse--differential involvement of A(2B) adenosine and P2X purinergic receptors.
Irnich D; Tracey DJ; Polten J; Burgstahler R; Grafe P
Neuroscience; 2002; 110(1):123-9. PubMed ID: 11882377
[TBL] [Abstract][Full Text] [Related]
19. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
20. ATP P2 receptors and regulation of bone effector cells.
Gallagher JA
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):125-7. PubMed ID: 15615109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
